跳至主要内容
临床试验/NCT01765010
NCT01765010Unknown4 期

Comparisons of the Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
88
试验地点
1
主要终点
Change of serum sclerostin level

研究概览

简要总结

The purpose of this study is to compare the effect of inactive and active vitamin D on serum sclerostin and dickkopf1 levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male volunteer older than 20 years

排除标准

  • Subjects with bone and mineral metabolism disorders
  • Subjects with kidney or liver diseases
  • Subjects with uncorrectable hypercalcemia or hypocalcemia
  • Subjects with chronic gastrointestinal disorders or malabsorption
  • Subjects taking medication related to bone loss

研究组 & 干预措施

Placebo control

Placebo Comparator

Placebo control

干预措施: Placebo (Drug)

Cholecalciferol 1000IU

Active Comparator

Cholecalciferol 1000IU qd for 8 weeks

干预措施: Cholecalciferol (Drug)

alfacalcidol

Experimental

alfacalcidol 0.5ug qd for 8 weeks

干预措施: Alfacalcidol (Drug)

Calcitriol

Experimental

Calcitriol 0.25ug qd for 8 weeks

干预措施: Calcitriol (Drug)

结局指标

主要结局

Change of serum sclerostin level

时间窗: 8 weeks later

Change of serum Dickkopf1 level

时间窗: 8 weeks later

次要结局

  • Change of serum c-telopeptide level(8 weeks later)
  • Change of serum bone-specific alkaline phosphatase level(8 weeks later)
  • Change of serum calcium level(8 weeks later)
  • Change of serum parathyroid hormone level(8 weeks later)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Effect of Inactive and Active Vitamin D on Serum... | 临床试验